Toxic amino acids, peptides, and proteins — which first evolved as molecular weapons deployed by species in conflict — can also serve as blueprints for pharmaceutical innovation.| www.asimov.press
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.| U.S. Food and Drug Administration